This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Trauma patients administered oral THC consume fewer opioids than do similarly matched controls, according to clinicaltrialdata published in the journal Trauma Surgery & Acute Care. These opioid-sparing effects were most pronounced among participants who had prior experience with cannabis.
MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. In September 2021, MoreBetter hosted a self-reported data collection with this CBN tincture offered to participants for free of charge from CBDistillery. Back to our study.
The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. About RYAH Group, Inc. RYAH Group, Inc.
Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. How to Use the Data. Advantages of Data, Macro, and Micro. RYAH Group Inc.
Auditory & Other Symptoms The survey, whose findings were published in February 2023 in the Journal of Otolaryngology – Head & Neck Surgery 1 evaluated cannabis perceptions and consumption among 45 adult tinnitus patients randomly selected and recruited from an outpatient ear, nose, and throat clinic in Ontario, Canada.
Clinicaltrials into cannabis’ potential as an opioid replacement are well underway in South Africa. We are currently recruiting patients, and data-capturing all the questionnaires and feedback from the patients for the live study. Quite frankly, the clinicaltrials couldn’t have come at a better time.
Not only this, but Gaize recently completed the largest clinicaltrial into cannabis impairment , and the results are set to transform the realm of workplace and road safety. A separate study published in Frontiers in Psychiatry found that consumption increased the risk of traffic crashes by 50%. Here’s what he had to say.
Of these consumers, over half said the drug had a beneficial clinical effect on their condition. However, the survey also revealed that, among the Parkinson’s disease patients , there was a noticeable knowledge gap concerning the different methods of consumption available and the individual effects of THC and CBD.
The study was conducted by more than 10 researchers, with leads Dr. Jodi Gilman and Dr. Kevin Potter taking responsibility for the integrity and accuracy of the data. ClinicalTrial Sample Size. Does the Data Justify the Conclusions? Investigating the Impact of MMJ Cards.
The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.
A data firm is warning those infected with the novel coronoavirus to avoid consuming products that contain tetrahydrocannabinol (THC), the main psychoactive component of cannabis. Data CEO Julie Armstrong said her company knows the COVID-19 affects the population in a similar way to influenza.
The disparities in consumption could be attributed to the fact that Japan implements harsh laws forbidding the use, production, and importation of illicit substances. Data suggests that the market has inflated from JPY4 billion (USD$3 billion) in 2019 to JPY17 billion (USD$13 billion) in 2022. Around 0.2%
As the team predicted, ketamine did stop uncontrollable movements for a total of three days before returning 10 days post-consumption as baseline involuntary movement. Based on preclinical data results and five case studies in PD patients, University of Arizona associate professors Scott Sherman, MD, Ph.D., and Torsten Falk, Ph.D.,
The double-blind, randomised, placebo-controlled clinicaltrial took place over two years between 2017 and 2019 at the Center for Medicinal Cannabis Research at the University of California. hours after consumption. hours after consumption. Further simulator tests were given at 30 minutes, 1.5, hours after smoking.
” Clinicaltrialdata published in 2017 in in the journal European Neuropsychopharmacology previously reported that the administration of whole-plant cannabis extracts is associated with improvements in cognition and behavior in subjects with ADHD. 9-tetrahydrocannabinol (THC).
Over time extended clinicaltrials will continue to map out the plant’s therapeutic effects, supporting it as an alternative medicine offering relief for a long list of conditions. There simply isn’t enough research on cannabis to support its efficacy, especially in comparison to traditional medicine like opioids.
However, the scientific data on CBG is nowhere near as developed as what we have on CBD. The vast majority of what we know about CBD’s medicinal effects is based on laboratory studies, is far from being properly understood, and lacks solid scientific data on human subjects — aside from epilepsy 5.
o Technology powered research: Virtual clinicaltrials and other accelerated technologies that mix the potential of new technologies with cannabis to create research insights quickly and more accurately, are being classified as Cannabis 3.0, triggering new innovations and improved data quality through better user experiences.
Currently, the FDA treats CBD products aimed at human or animal consumption as drugs and therefore they cannot be distributed without prior approval or a rulemaking exception (more on this below). The FDA is collecting data to fill these gaps. And now, it appears, based on Dr. Under section 331(ll) of the FD&C Act (21 U.S.C.
As with any prescription, marijuana does not offer a one-size-fits-all solution: there are a range of products available with different strains, chemical structures, dosages, and forms of consumption that all can impact the effectiveness for each user. Research is ongoing, but the existing data and anecdotal reports show potential.
Their audacious vision to reimagine traditional pharma efficacy trials promises to rapidly and accurately determine which nutraceuticals and natural molecules actually work for which conditions,” said Diamandis. Radicle Science also announced a new CTO, Sheldon Borkin , PhD, who joined in September 2021.
Studies of crash or driving data suggest that, although permissive marijuana policies are associated with higher prevalence of tetrahydrocannabinol (THC) presence among drivers [ 1 , 2 ], there is mixed evidence that these policies are associated with motor vehicle crashes [ 3 , 4 , 5 , 6 , 7 , 8 , 9 ]. never vs. at least once). (2)
It is important that they conduct medical research into the safety and effectiveness of cannabis products through adequate and well-controlled clinicaltrials. Some states require mandatory warning statements in advertisements for medical cannabis. required to provide other warnings that may be needed by the commission.
According to a new study titled Use of cannabinoids for the treatment of patients with post-traumatic stress disorder, the consumption of cannabinoids and cannabinoid products is safe and effective in the mitigation of symptoms of post-traumatic stress (PTS).
The Delaware Senate passes legislation making violation of cannabis consumption/possession laws by minors a civil rather than criminal infraction. Herbal cannabis is safe and effective in patients diagnosed with fibromyalgia , according to clinicaldata published this month in the Journal of Clinical Medicine.
At the same time, the outlook on cannabis research data is largely positive. Data collection. One coder then independently coded the entire dataset and entered the data into NVivo v12. This offers a more denotative approach to complement the data. The coding method was a combination of deductive and inductive codes.
Positive and Negative Syndrome Scale [PANSS] positive subscale) were highlighted as the secondary outcomes of cannabis consumption, in addition to various other cognitive, subjective, pleasurable, pharmacological, and physiological effects. Cannabis Consumption Increased Post-Pandemic, Stimulating Research.
Over 200 scientists from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpiblished data. None of the participants had been using any cannabinoid-based products prior to this study.
Just over 500 participants from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpublished data. None of the participants had been using any cannabinoid-based products prior to this study.
While plenty of preclinical evidence exists demonstrating the anti-cancer effects of cannabinoids, clinicaltrials investigating relationships between cannabis use and cancer outcomes in actual patients are rare. Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome.”
A clinicaltrial published in 2015 found that the test subjects had “significantly higher blood THC” levels when they used cannabis along with alcohol, and combining the two led to increased performance impairment. Drink or smoke first: Does ‘weed before beer everything clear’ really matter? arguing while drinking.
Data shows that Hispanic Americans are more interested in using cannabis and CBD for wellness than other groups and “is believed to be in part due to the connections between the Hispanic community and nature.” Essay: “Crowdsourcing User Experience Data for a Targeted Medical Cannabis Journey with Cannamunity” .
To date, very few human clinicaltrials have been conducted to assess the effectiveness of THC or CBD in treating cancer. While RSO has been subject to increased popularity in treating certain types of cancers, no clinicaltrials have tested the safety or efficacy of RSO in humans, meaning that all evidence is anecdotal.
According to data on Healthy Place , treatment for PTSD is typically accommodated for the general public, of who the vast majority have not experienced military combat. A 2019 study by Stephanie Lake and colleagues conducted an analysis of health survey data from more than 24 thousand Canadians who had PTSD.
The PK data on cats shows there are differences in absorption between cats and dogs and that dosing may be different between these two species and that our chew form is likely to be more absorbable than oils in general. This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.
In 2011, researchers published cross-sectional data from two population-based surveys including over 50,000 respondents. Stimulating CB1 receptors with THC results in up-regulation across the board (meaning most patients will experience an increase in appetite and calorie consumption). Believe it or not, science says: YES.
Few randomized clinicaltrials have been conducted or are planned to explore the effects of marijuana on cardiovascular risk. Screening and testing for use of marijuana are encouraged in clinical settings, especially in the care of young patients presenting with cardiovascular disease. More research is needed.
Whereas with cannabis, never mind that you don’t have any medical guidance to this usually, but you have to pick a product and not just the consumption method. CP: Right now, over consumption. That there’s not enough information about, there’s not enough clinicaltrials, and there’s not enough this and that.
According to the American Journal of Clinical Nutrition : Our systematic review and meta-analysis of prospective cohort studies and randomized controlled trials provides evidence that sugar-sweetened beverage consumption promotes weight gain in children and adults. Cannabis: 1. Not for the faint of heart. Cannabis: 3.
To get their results, the researchers, who were primarily from the US’s National Institutes of Health (NIH), looked at select data from a clinicaltrial that investigated the effects of aspirin in pregnant women. Limited conclusions.
Treating migraine pain is one of the instances where inhaled cannabis consumption, such as smoking or vaping , is important for the right effects and speed of delivery. Daily cannabis consumption was an effective treatment for 85% of participants. Topical cannabis products can also be useful, but research and data is very limited.
Even though these effects were observed on mice, all mammals have neurological and cellular similarities, and the team in charge of this study concluded that: “With respect to the treatment of ALS, from both a disease modifying and symptom management viewpoint, clinicaltrials with cannabis are the next logical step.
The IMH concluded that “cannabis consumption is associated with irreversible brain damage, brain shrinkage and serious mental/psychiatric illnesses. There is even published research, derived from clinicaltrials, on the potential uses of cannabinoids to manage seizures and epilepsy, cited the ministries.
To get their results, the researchers, who were primarily from the US’s National Institutes of Health (NIH), looked at select data from a clinicaltrial that investigated the effects of aspirin in pregnant women. Limited conclusions.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content